Prebypass filtration of cardiopulmonary bypass circuits: An outdated technique?

Perfusion

Volumn 18, Issue SUPPL. 1, 2003, Pages 81-88

  Merkle, Frank ^a   Böttcher, Wolfgang ^a   Hetzer, Roland ^a  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOPLEGIC AGENT; ENDOTOXIN; INFUSION FLUID;

ARTERY; ARTICLE; BLOOD FILTRATION; CARDIOPULMONARY BYPASS; CONTAMINATION; CRYSTALLOID; EXTRACORPOREAL CIRCULATION; GAS EMBOLISM; HUMAN; INFLAMMATION; MEMBRANE FILTER; MICROEMBOLISM; MORBIDITY; PARTICLE SIZE; PRIORITY JOURNAL;

CARDIOPLEGIC SOLUTIONS; CARDIOPULMONARY BYPASS; EMBOLISM, AIR; FILTRATION; HUMANS; OXYGENATORS, MEMBRANE; PARTICLE SIZE;

EID: 0037272272     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1191/0267659103pf632oa     Document Type: Article

References (60)

1. Fearn SJ, Pole R, Wesnes K, Faragher EB, Hooper TL, McCollum CN. Cerebral injury during cardiopulmonary bypass: Emboli impair memory. J Thorac Cardiovasc Surg 2001; 121: 1150-60.
2. Baker AJ, Naser B, Benaroia M, Mazer CD. Cerebral microemboli during coronary artery bypass using different cardioplegia techniques. Ann Thorac Surg 1995; 59: 1187-91.
3. Silbert BS, Scott DA, Doyle TJ, Blyth C, Borton MC, O'Brien JL, De L, Horne D. Neuropsychologic testing within 18 hours after cardiac surgery. J Cardiothorac Vasc Anesth 2001; 15: 20-24.
4. Newman MF, Kirchner JL, Phillips-Bute B, Gaver V, Grocott H, Jones RH, Mark DB, Reves JG, Blumenthal JA. Longitudinal assessment of neurocognitive function after coronary artery bypass surgery. N Engl J Med 2001; 344: 395-402.
5. Nussmeier NA. A review of risk factors for adverse neurologic outcome after cardiac surgery. J Extra Corpor Technol 2002; 34: 4-10.
6. Blauth CI. Macroemboli and microemboli during cardiopulmonary bypass. Ann Thorac Surg 1995; 59: 1300-303.
7. Walpot H, Franke RP, Burchard WG, Agternkamp C, Muller FG, Mittermayer C, Kalff G. [Particulate contamination of infusion solutions and drug additives within the scope of long-term intensive therapy. 1. Energy dispersion electron images in the scanning electron microscope-REM/EDX]. Anaesthesist 1989; 38: 544-48.
8. Challa VR, Moody DM, Troost BT. Brain embolic phenomena associated with cardiopulmonary bypass. J Neurol Sci 1993; 117: 224-31.
9. Orenstein JM, Sato N, Aaron B, Buchholz B, Bloom S. Microemboli observed in deaths following cardiopulmonary bypass surgery: silicone antifoam agents and polyvinyl chloride tubing as sources of emboli. Hum Pathol 1982; 13: 1082-90.
10. Dewanjee MK, Wu SM, Kapadvanjwala M, De D, Dewanjee S, Gonzalez L, Novak S, Hsu LC, Perryman RA, Duncan RC, Serafini AN, Sfakianakis GN, Horton AF. Emboli from an extraluminal blood flow hollow fiber oxygenator with and without an arterial filter during cardiopulmonary bypass in a pig model. ASAIO J 1996; 42: 1010-18.
11. Murkin JM. Anesthesia, the brain, and cardiopulmonary bypass. Ann Thorac Surg 1993; 56: 1461-63.
12. Kirkpatrick CJ. Aspects of the Pathogenesis of multiple organ failure. ECC International 1990; 2: 177-82.
13. Bundesministerium für Gesundheit. Dreiunddreissigste Bekanntmachung zum Arzneibuch (Monographien des Europäischen Arzneibuchs). Bundesanzeiger, 2000: 244.
14. Kurusz M, Christman EW, Williams EH, Tyers GFO. Roller pump induced tubing wear: Another argument in favor of arterial line filtration. J Extra Corpor Technol 1980; 12: 49-59.
15. Leong AS, Disney AP, Gove DW. Spallation and migration of silicone from blood-pump tubing in patients on hemodialysis. N Engl J Med 1982; 306: 135-40.
16. Briceno JC, Runge TM. Tubing spallation in extracorporeal circuits. An in vitro study using an electronic particle counter. Int J Artif Organs 1992; 15: 222-28.
17. Hoenich NA, Thompson J, Varini E, McCabe J, Appleton D. Particle spallation and plasticiser (DEHP) release from extracorporeal circuit tubing materials. Int J Artif Organs 1990; 13: 55-62.
18. Knopp EA, Baumann FG, Pratt D, Faden R, Catinella FP, Nathan IM, Adams PX, Cunningham JN Jr, Spencer FC. Release of particulate matter from extracorporeal tubing: ineffectiveness of standard arterial line filters during bypass. J Cardiovasc Surg (Torino) 1982; 23: 470-76.
19. Peek GJ, Thompson A, Killer HM, Firmin RK. Spallation performance of extracorporeal membrane oxygenation tubing. Perfusion 2000; 15: 457-66.
20. Takano T, Nakata K, Schulte-Eistrup S, Kawahito S, Glueck J, Clarke IC, Williams PA, Maeda T, Nonaka K, Linneweber J, Yoshikawa M, Fujisawa A, Makinouchi K, Yokokawa M, Nose Y. Particles released from the Gyro C1E3 during simulated extracorporeal circulation. Artif Organs 2000; 24: 446-49.
21. Simmons E, MaGuire C, Lichti E, Helvey W, Almond C. A comparison of the microparticles produced when two disposable-bag oxygenators and a disc oxygenator are used for cardiopulmonary bypass. J Thorac Cardiovasc Surg 1972; 63: 613-21.
22. Reed CC, Romagnoli A, Taylor DE, Clark DK. Particulate matter in bubble oxygenators. J Thorac Cardiovasc Surg 1974; 68: 971-74.
23. Pastoriza-Pinol J, Mc Millan J, Smith BF, Sandy M, Lancucki C, Stirling GR, Newland PE. An analysis of micro-embolic particles originating in the extra-corporeal circuit before bypass. J Extra Corpor Technol 1979; 11: 221-28.
24. Ueda M, Kondo Y, Fuse K, Makuuchi H, Konishi T. Removal of particle contamination in the extracorporeal circuit detected by an in-line particle counter. J Extra Corpor Technol 1989; 21: 24-28.
25. Liu JF, Su ZK, Ding WX. Quantitation of particulate microemboli during cardiopulmonary bypass: experimental and clinical studies. Ann Thorac Surg 1992; 54: 1196-202.
26. Swanney PJ. A comparative study of five filtered cardiotomy reservoirs. J Extra Corpor Technol 1986; 18: 7-11.
27. Backhouse CM, Ball PR, Booth S, Kelshaw MA, Potter SR, McCollum CN. Particulate contaminants of intravenous medications and infusions. J Pharm Pharmacol 1987; 39: 241-45.
28. Pecar A, Dirks B. Mixtures of infusion solutions and drugs. Compatibility and incompatibility. Anaesthesist 1995; 44: 793-803.
29. Cecere G, Groom R, Forest R, Quinn R, Morton J. A 10-year review of pediatric perfusion practice in North America. Perfusion 2002; 17: 83-89.
30. Kirkpatrick CJ, Lehr HA, Otto M, Bittinger F, Rangoonwala, R. Clinical implications of circulating particulate contamination of parenteral injections: a review. Crit Care Shock 1999; 2: 166-73.
31. Gaillard D, Barthelemy R, Bouilhac M, Cognard JC, Perroud A. Particulate contamination of priming solutions and their manipulation. Cah CECEC 1984; June: 65-67.
32. Machin D. An investigation of particulate contamination in various priming solutions including the pre-bypass circuit. Perfusionist 1995; January: 9-11.
33. Hearse DJ, Erol C, Robinson LA, Maxwell MP, Braimbridge MV. Particle-induced coronary vasoconstriction during cardioplegic infusion. Characterization and possible mechanisms. J Thorac Cardiovasc Surg 1985; 89: 428-38.
34. Robinson LA, Braimbridge MV, Hearse DJ. The potential hazard of particulate contamination of cardioplegic solutions. J Thorac Cardiovasc Surg 1984; 87: 48-58.
35. Hellinger A, Piotrowski J, Konerding MA, Burchard WG, Doetsch N, Peitgen K, Erhard J, Reidemeister JC. Impact of particulate contamination in crystalloid cardioplegic solutions: studies by scanning and transmission electron microscopy. Thorac Cardiovasc Surg 1997; 45: 20-26.
36. Muth CM, Shank ES. Gas embolism. N Engl J Med 2000; 342: 476-82.
37. Kurusz M, Butler B, Katz J, Conti VR. Air embolism during cardiopulmonary bypass. Perfusion 1995; 10: 361-91.
38. Dexter F, Hindman BJ, Marshall JS. Estimate of the maximum absorption rate of microscopic arterial air emboli after entry into the arterial circulation during cardiac surgery. Perfusion 1996; 11: 445-50.
39. Borger MA, Peniston CM, Weisel RD, Vasiliou M, Green RE, Feindel CM. Neuropsychologic impairment after coronary bypass surgery: effect of gaseous microemboli during perfusionist interventions. J Thorac Cardiovasc Surg 2001. 121: 743-9.
40. Taylor RL, Borger MA, Weisel RD, Fedorko L, Feindel CM. Cerebral microemboli during cardiopulmonary bypass: increased emboli during perfusionist interventions. Ann Thorac Surg 1999; 68: 89-93.
41. Borger MA, Feindel CM. Cerebral emboli during cardiopulmonary bypass: effect of perfusionist interventions and aortic cannulas. J Extra Corpor Technol 2002; 34: 29-33.
42. Schonburg M, Urbanek P, Erhardt G, Kraus B, Taborski U, Muhling A, Hein S, Roth M, Tiedtke HJ, Klovekorn WP. Significant reduction of air microbubbles with the dynamic bubble trap during cardiopulmonary bypass. Perfusion 2001; 16: 19-25.
43. Wheeldon DR, Bethune DW, Gill RD. Vortex pumping for routine cardiac surgery: a comparative study. Perfusion 1990; 5: 135-43.
44. Willcox TW, Mitchell SJ, Gorman DF. Venous air in the bypass circuit: a source of arterial line emboli exacerbated by vacuum-assisted drainage. Ann Thorac Surg 1999; 68: 1285-89.
45. Mitchell SJ, Willcox T, Gorman DF. Bubble generation and venous air filtration by hard-shell venous reservoirs: a comparative study. Perfusion 1997; 12: 325-33.
46. Beckley PD, Shinko PD, Sites JP. A comparison of gaseous emboli release in five membrane oxygenators. Perfusion 1997; 12: 133-41.
47. Karichev ZR, Muler AL, Vishnevsky ME. Spontaneous gas bubbling in microporous oxygenators. Artif Organs 1999; 23: 904-909.
48. Andersen LW, Baek L, Degn H, Lehd J, Krasnik M, Rasmussen JP. Presence of circulating endotoxins during cardiac operations. J Thorac Cardiovasc Surg 1987; 93: 115-19.
49. Neuhof C, Wendling J, Dapper F, Bauer J, Zickmann B, Jochum M, Tillmanns H, Neuhoft H. Endotoxemia and cytokine generation in cardiac surgery in relation to flow mode and duration of cardiopulmonary bypass. Shock 2001; 16(Suppl 1): 39-43.
50. Nieman G, Searles B, Carney D, McCann U, Schiller H, Lutz C, Finck C, Gatto LA, Hodell M, Picone A. Systemic inflammation induced by cardiopulmonary bypass: a review of pathogenesis and treatment. J Extra Corpor Technol 1999; 31: 202-10.
51. Bach A, Bottiger BW. Microfilters within the scope of infusion therapy - possibilities and problems in retention of microbial and particle contaminants. Zentralbl Chir 1994; 119: 268-75.
52. Richards, C, Grassby PF. A comparison of the endotoxin-retentive abilities of two '96-h' in-line intravenous filters. J Clin Pharm Ther 1994; 19: 199-202.
53. Hughes CF, Grant AF, Leckie BD, Baird DK. Cardioplegic solution: a contamination crisis. J Thorac Cardiovasc Surg 1986; 91: 296-302.
54. Marshall L. Filtration in cardiopulmonary bypass: past, present and future. Perfusion 1988; 3: 135-47.
55. Kemna GD, Docherty JP. Why filter the cardiopulmonary circuit prebypass? J Extra Corpor Technol 1979; 11: 119-30.
56. Brooks JD, Beauchamp RA, Magrath RA, Clark RE. Efficacy of particulate removal by a prebypass filter with different oxygenation systems. J Extra Corpor Technol 1979; 11: 175-82.
57. Uretzky G, Landsburg G, Cohn D, Wax Y, Borman JB. Analysis of microembolic particles originating in extracorporeal circuits. Perfusion 1987; 2: 9-17.
58. Klak K. Umfrageergebnisse zum Ist-Zustand der Kardiotechnik in deutschen Herzzentren 1997. Cologne: Deutsche Gesellschaft fuer Kardiotechnik, 1997.
59. Stammers AH, Mejak BL. An update on perfusion safety: does the type of perfusion practice affect the rate of incidents related to cardiopulmonary bypass? Perfusion 2001; 16: 189-98.
60. Merkle F, Böttcher W, Hetzer R. Reduction of microemboli count in the priming fluid of CPB circuits. J Extra Corpor Technol, in press.